These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36317165)

  • 61. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
    Oderda M; Diamand R; Albisinni S; Calleris G; Carbone A; Falcone M; Fiard G; Gandaglia G; Marquis A; Marra G; Parola C; Pastore A; Peltier A; Ploussard G; Roumeguère T; Sanchez-Salas R; Simone G; Smelzo S; Witt JH; Gontero P
    BJU Int; 2021 Mar; 127(3):318-325. PubMed ID: 32869940
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Robot-assisted extended pelvic lymph node dissection in prostate cancer. When and how?
    Sierra PS; Lestingi JFP; Albuquerque EV; Pontes J; de Carvalho PA; Cavalcante A; Guglielmetti GB; Nahas WC; Coelho RF
    Arch Esp Urol; 2019 Apr; 72(3):257-265. PubMed ID: 30945652
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy.
    Bivalacqua TJ; Pierorazio PM; Gorin MA; Allaf ME; Carter HB; Walsh PC
    Urology; 2013 Sep; 82(3):653-8. PubMed ID: 23987158
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy.
    Gandaglia G; Suardi N; Gallina A; Abdollah F; Capitanio U; Salonia A; Colombo R; Bianchi M; Chun FK; Hansen J; Rigatti P; Montorsi F; Briganti A
    J Sex Med; 2012 Aug; 9(8):2187-94. PubMed ID: 22738395
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Variation in pelvic lymph node dissection among patients undergoing radical prostatectomy by hospital characteristics and surgical approach: results from the National Cancer Database.
    Wang EH; Yu JB; Gross CP; Smaldone MC; Shah ND; Trinh QD; Nguyen PL; Sun M; Han LC; Kim SP
    J Urol; 2015 Mar; 193(3):820-5. PubMed ID: 25242393
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The learning curve for laparoscopic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer: implications for compliance with existing guidelines.
    Eden CG; Zacharakis E; Bott S
    BJU Int; 2013 Aug; 112(3):346-54. PubMed ID: 23419154
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PSMA PET Scan Era: A Changing Paradigm PSMA PET and Lymph Node Dissection for Prostate Cancer Management.
    Haxhimolla J; Kua B; Gilbourd D; Haxhimolla H
    Semin Oncol Nurs; 2020 Aug; 36(4):151044. PubMed ID: 32723519
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Significant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissection.
    Pose RM; Knipper S; Würnschimmel C; Tennstedt P; Michl U; Maurer T; Graefen M; Steuber T
    BJU Int; 2021 Dec; 128(6):728-733. PubMed ID: 34036733
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of perioperative complications for extended vs standard pelvic lymph node dissection in patients undergoing radical prostatectomy for prostate cancer: a meta-analysis.
    Kong J; Lichtbroun B; Sterling J; Wang Y; Wang Q; Singer EA; Jang TL; Ghodoussipour S; Kim IY
    Am J Clin Exp Urol; 2022; 10(2):73-81. PubMed ID: 35528467
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
    Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
    Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Robotic extended pelvic lymphadenectomy for bladder cancer with increased nodal yield.
    Lavery HJ; Martinez-Suarez HJ; Abaza R
    BJU Int; 2011 Jun; 107(11):1802-5. PubMed ID: 21070571
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Extended lymph node dissection in robotic radical prostatectomy: Current status.
    Chopra S; Alemozaffar M; Gill I; Aron M
    Indian J Urol; 2016; 32(2):109-14. PubMed ID: 27127352
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lymphocele after extraperitoneal robot-assisted radical prostatectomy: a propensity score-matching study.
    Lee JY; Diaz RR; Cho KS; Yu HS; Chung JS; Ham WS; Choi YD
    Int J Urol; 2013 Dec; 20(12):1169-76. PubMed ID: 23521086
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection.
    Porcaro AB; Tafuri A; Panunzio A; Mazzucato G; Cerrato C; Gallina S; Bianchi A; Rizzetto R; Amigoni N; Serafin E; Cianflone F; Orlando R; Gentile I; Migliorini F; Zecchini Antoniolli S; Di Filippo G; Brunelli M; Pagliarulo V; Cerruto MA; Antonelli A
    Int Urol Nephrol; 2022 Mar; 54(3):541-550. PubMed ID: 35044553
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy.
    Tyritzis SI; Wilderäng U; Lantz ΑW; Steineck G; Hugosson J; Bjartell A; Stranne J; Haglind E; Wiklund NP
    Urol Oncol; 2020 Jan; 38(1):5.e1-5.e8. PubMed ID: 31445896
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is a Drain Needed After Robotic Radical Prostatectomy With or Without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial.
    Porcaro AB; Siracusano S; Bizzotto L; Sebben M; Cacciamani GE; de Luyk N; Corsi P; Tafuri A; Processali T; Mattevi D; Cerruto MA; Brunelli M; Novella G; De Marco V; Artibani W
    J Endourol; 2021 Jun; 35(6):922-928. PubMed ID: 30398382
    [No Abstract]   [Full Text] [Related]  

  • 79. Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches.
    Bianchi L; Gandaglia G; Fossati N; Suardi N; Moschini M; Cucchiara V; Bianchi M; Damiano R; Schiavina R; Shariat SF; Montorsi F; Briganti A
    Urologia; 2017 Feb; 84(1):9-19. PubMed ID: 26689534
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
    Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.